Deepti Singh
FounderChief Scientific Officer & Co-founder at InGel Website
Boston, Massachusetts, United States
FoundedInGel Website
Find your path to Deepti
314 people in our graph share verified history with Deepti — schools, employers, funds. One of them is your warm intro.
About
Deepti Singh is the Founder and Chief Scientific Officer of InGel Therapeutics, Inc. She holds a Ph.D. focused on biomaterial-based tissue regeneration and has research experience at Yale and Harvard University, with specializations including ocular regeneration, biomaterials, polymer-based cell delivery, and stem cell therapies. Her current work involves the clinical translation of cell-based therapies for blinding diseases.
Chief Scientific Officer & Co-founder at InGel Website
Intro paths
In turn, Deepti can intro founders to InGel Website's investors below.
InGel Website's investors · 4
Co-founders at InGel Website

Experience
- InGel Therapeutics, Inc.Founder and Chief Scientific Officercurrent2021 — presentUnited States
- Mass. Eye and EarResearch Fellow BE2018 — 2024Greater Boston Area
- Harvard Medical SchoolResearch Fellow2018 — 2024Greater Boston Area
- Yale School of MedicineAssociate Research Scientist2016 — 2018New Haven, Connecticut Area
- Yale School of MedicinePostdoctoral Research Associate2015 — 2016
- Yeungnam UniversityPostdoctoral Fellow/ International Research Professor2011 — 2014Gyeongsan, Gyeongsangbuk-do, Korea
- Indian Institute of Technology, KanpurResearch Fellow2008 — 2011Kanpur Area, India
Skills & more
+10 more
Polymerase Chain Reaction (PCR)Confocal MicroscopyLife SciencesMicroscopyBiotechnologyReal-Time Polymerase Chain Reaction (qPCR)MiceConfocal microscopyIn-vivoSub-retinal injection- Biomedical / Clinical Research Investigators — CITI Program
- Fellows Responsible Conduct of Research — CITI Program
- Conflicts of Interest — CITI Program
- CITI Good Clinical Practice — CITI Program
- MCB80.3x: Fundamentals of Neuroscience, Part 3: The Brain — HarvardX - An Online Learning Initiative by Harvard University through edX
- Fundamentals of Neuroscience, Part 2: Neurons and Networks — HarvardX - An Online Learning Initiative by Harvard University through edX
- Fundamentals of Neuroscience, Part 1: The Electrical Properties of the Neuron — HarvardX - An Online Learning Initiative by Harvard University through edX
From Deepti's professional profile.
Frequently asked questions
- Who is Deepti Singh?
- Deepti Singh is the Founder and Chief Scientific Officer of InGel Therapeutics, Inc. She holds a Ph.D. focused on biomaterial-based tissue regeneration and has research experience at Yale and Harvard University, with specializations including ocular regeneration, biomaterials, polymer-based cell delivery, and stem cell therapies. Her current work involves the clinical translation of cell-based therapies for blinding diseases.
- Where does Deepti Singh work?
- Deepti Singh is Chief Scientific Officer & Co-founder of InGel Website.
- What companies did Deepti Singh found?
- Deepti Singh founded InGel Website.
- Where did Deepti Singh go to school?
- Deepti Singh studied at Dr M G R Educational and Research Institute (Doctor of Philosophy (Ph.D.), Biotechnology/ Genetics); University of Madras (General Genetics/Immunology, Human/Medical Genetics); University of Madras (Microbiology, Microbiology).
Founder mafias
University of Madras mafia38
Also came through, then founded or led a company.
Dr MGR Educational and Research Institute mafia3
Also came through, then founded or led a company.
Same school
Also attended Dr M G R Educational and Research Institute2
Also attended University of Madras100
+ 94 more
Shared employers
Also worked at InGel Therapeutics, Inc.1
Also worked at Mass. Eye and Ear10
+ 4 more
Also worked at Harvard Medical School337
+ 331 more
Also worked at Yale School of Medicine79
+ 73 more




































